RMD Stock Price Chart More Charts

RMD Price/Volume Stats

ResMed Inc. (RMD) Company Bio

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing. The company was founded in 1989 and is based in San Diego, California.

RMD Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Resmed Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Resmed Inc ranked in the 16st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for RMD, they are:

• The company's debt burden, as measured by earnings divided by interest payments, is 13.19 -- which is good for besting 73.75% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
• The business' balance sheet suggests that 5% of the company's capital is sourced from debt; this is greater than merely 17.1% of the free cash flow producing stocks we're observing.
• RMD's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 52.18% of tickers in our DCF set.

Want more companies with a valuation profile/forecast similar to that of Resmed Inc? See AMPH, HAE, PKI, QGEN, and ZBH.